Debt to EBITDA ratio Analysis of Novavax Inc - Deep Dive
Debt to EBITDA of NVAX
Dec-23-0.306Very Poor Debt to EBITDA | Dec-22-0.858Very Poor Debt to EBITDA | Growth64.35% |
Debt to EBITDA Analysis of Novavax Inc
Debt to EBITDA Ratio of NVAX rose handsomely by 64.35 % this year. |
Debt to EBITDA Ratio with value of -0.270 was highest in Year Dec-21 in last Five Years. |
Debt to EBITDA Ratio with value of -2.80 was lowest in Year Dec-19 in last Five Years. |
Latest Debt to EBITDA Ratio with value of -0.306 is Greater than Average Debt to EBITDA of -1.17 in last five years. |
Other Debt to EBITDA Related Info of NVAX that may interest you.
Novavax Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
NVAX | 15.03 | 15.25 | 1.44 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..Debt to EBITDA Related Ratios
CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
Poor Stability Stock |
FY - Historical Debt to EBITDA of Novavax Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Debt to EBITDA | -0.306 | -0.858 | -0.270 | -1.62 | -2.80 | -2.09 | -3.98 |
Change | 64.35 % | -217.46 % | 83.30 % | 42.30 % | -34.03 % | 47.39 % | -197.04 % |
FY Chart of Debt to EBITDA of Novavax Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)